Does glucagon-like peptide-1 (GLP-1) receptor agonist stimulation reduce alcohol intake in patients with alcohol dependence: study protocol of a randomised, double-blinded, placebo-controlled clinical trial

INTRODUCTION: Alcohol dependence is a major public health problem. It is underdiagnosed and undertreated. Even when treated, more than 2/3 of patients in abstinence-oriented treatment will relapse within the first year. Thus, there is an urgent need for efficacious medical treatment of alcohol depen...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonsen, Kerstin K, Klausen, Mette K, Brunchmann, Amanda S, le Dous, Nina, Jensen, Mathias E, Miskowiak, Kamilla Woznica, Fisher, Patrick M, Thomsen, Gerda K, Rindom, Henrik, Fahmy, Thomas P, Vollstaedt-Klein, Sabine, Benveniste, Helene, Volkow, Nora D, Becker, Ulrik, Ekstrøm, Claus, Knudsen, Gitte Moos, Vilsbøll, Tina, Fink-Jensen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Addiction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082448/
https://www.ncbi.nlm.nih.gov/pubmed/30012779
http://dx.doi.org/10.1136/bmjopen-2017-019562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082448/
https://www.ncbi.nlm.nih.gov/pubmed/30012779
http://dx.doi.org/10.1136/bmjopen-2017-019562

Ejemplares similares